Ricky Goldwasser
Stock Analyst at Morgan Stanley
(3.82)
# 666
Out of 4,876 analysts
236
Total ratings
64.15%
Success rate
22.11%
Average return
Main Sectors:
Stocks Rated by Ricky Goldwasser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Overweight | $270 → $283 | $260.59 | +8.60% | 16 | Jun 11, 2025 | |
| CNC Centene | Initiates: Overweight | $70 | $53.99 | +29.65% | 11 | Jun 9, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $563 → $374 | $309.11 | +20.99% | 17 | May 14, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $71 → $60 | $61.09 | -1.78% | 10 | Apr 24, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $220 → $184 | $150.01 | +22.66% | 22 | Feb 5, 2025 | |
| LFST LifeStance Health Group | Reiterates: Overweight | $10 | $5.15 | +94.17% | 8 | Apr 22, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $8 → $5.5 | $4.90 | +12.24% | 9 | Nov 10, 2023 | |
| OSCR Oscar Health | Maintains: Equal-Weight | $5 → $7.5 | $20.41 | -63.25% | 6 | Aug 30, 2023 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $19 → $12 | $13.85 | -13.36% | 8 | Aug 30, 2023 | |
| DGX Quest Diagnostics | Reiterates: Equal-Weight | $145 | $177.83 | -18.46% | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $297.05 | +22.87% | 7 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $403 → $420 | $725.78 | -42.13% | 27 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $120 | $7.94 | +1,411.34% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $549 → $620 | $241.88 | +156.33% | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $485 → $500 | $381.49 | +31.07% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $124 | $68.49 | +81.05% | 9 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $296 → $318 | $326.31 | -2.55% | 11 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $70 | $167.18 | -58.13% | 17 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $43 → $39 | $11.45 | +240.61% | 15 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $182 → $195 | $157.47 | +23.83% | 6 | Oct 21, 2020 |
Labcorp Holdings
Jun 11, 2025
Maintains: Overweight
Price Target: $270 → $283
Current: $260.59
Upside: +8.60%
Centene
Jun 9, 2025
Initiates: Overweight
Price Target: $70
Current: $53.99
Upside: +29.65%
UnitedHealth Group
May 14, 2025
Maintains: Overweight
Price Target: $563 → $374
Current: $309.11
Upside: +20.99%
Doximity
Apr 24, 2025
Maintains: Equal-Weight
Price Target: $71 → $60
Current: $61.09
Upside: -1.78%
Charles River Laboratories International
Feb 5, 2025
Maintains: Equal-Weight
Price Target: $220 → $184
Current: $150.01
Upside: +22.66%
LifeStance Health Group
Apr 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $5.15
Upside: +94.17%
GoodRx Holdings
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $8 → $5.5
Current: $4.90
Upside: +12.24%
Oscar Health
Aug 30, 2023
Maintains: Equal-Weight
Price Target: $5 → $7.5
Current: $20.41
Upside: -63.25%
Alignment Healthcare
Aug 30, 2023
Maintains: Overweight
Price Target: $19 → $12
Current: $13.85
Upside: -13.36%
Quest Diagnostics
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $145
Current: $177.83
Upside: -18.46%
Jul 14, 2023
Reiterates: Overweight
Price Target: $365
Current: $297.05
Upside: +22.87%
Jan 6, 2023
Maintains: Overweight
Price Target: $403 → $420
Current: $725.78
Upside: -42.13%
Jan 6, 2023
Maintains: Overweight
Price Target: $140 → $120
Current: $7.94
Upside: +1,411.34%
Oct 31, 2022
Maintains: Overweight
Price Target: $549 → $620
Current: $241.88
Upside: +156.33%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $485 → $500
Current: $381.49
Upside: +31.07%
Oct 11, 2022
Maintains: Overweight
Price Target: $127 → $124
Current: $68.49
Upside: +81.05%
Aug 17, 2022
Maintains: Overweight
Price Target: $296 → $318
Current: $326.31
Upside: -2.55%
Jul 14, 2022
Maintains: Overweight
Price Target: $74 → $70
Current: $167.18
Upside: -58.13%
Jul 6, 2022
Maintains: Underweight
Price Target: $43 → $39
Current: $11.45
Upside: +240.61%
Oct 21, 2020
Maintains: Overweight
Price Target: $182 → $195
Current: $157.47
Upside: +23.83%